Close Menu

This story has been updated to include comments from Arti Rai of Duke University.

NEW YORK – A US appellate court has revived a patent infringement suit brought by Illumina against Roche over non-invasive prenatal testing (NIPT) technology.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.